Expression and secretion of galectin‐12 in the context of neutrophilic differentiation of human promyeloblastic HL‐60 cells

Abstract Galectin‐12 is a tissue‐specific galectin that has been largely defined by its role in the regulation of adipocyte differentiation and lipogenesis. This study aimed to evaluate the role of galectin‐12 in the differentiation and polarization of neutrophils within a model of acute myeloid leukemia HL‐60 cells. All‐trans retinoic acid and dimethyl sulfoxide were used to induce differentiation of HL‐60 cells which led to the generation of two phenotypes of neutrophil‐like cells with opposite changes in galectin‐12 gene ( LGALS12 ) expression and different functional responses to N‐formyl‐ l ‐methionyl‐ l ‐leucyl‐ l ‐phenylalanine. These phenotypes showed significant differences of differentially expressed genes on a global scale based on bioinformatics analysis of available Gene Expression Omnibus (GEO) data sets. We also demonstrated that HL‐60 cells could secrete and accumulate galectin‐12 in cell culture medium under normal growth conditions. This secretion was found to be entirely inhibited upon neutrophilic differentiation and was accompanied by an increase in intracellular lipid droplet content and significant enrichment of 22 lipid gene ontology terms related to lipid metabolism in differentiated cells. These findings suggest that galectin‐12 could serve as a marker of neutrophilic plasticity or polarization into different phenotypes and that galectin‐12 secretion may be influenced by lipid droplet biogenesis.